Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup.

Complex PCI ICP ICP compleja Implante percutáneo de válvula aórtica Intervención coronaria percutánea PCI Percutaneous coronary intervention TAVI TAVR Transcatheter aortic valve replacement

Journal

Revista espanola de cardiologia (English ed.)
ISSN: 1885-5857
Titre abrégé: Rev Esp Cardiol (Engl Ed)
Pays: Spain
ID NLM: 101587954

Informations de publication

Date de publication:
17 May 2024
Historique:
received: 19 01 2024
accepted: 03 05 2024
medline: 20 5 2024
pubmed: 20 5 2024
entrez: 19 5 2024
Statut: aheadofprint

Résumé

In patients undergoing percutaneous coronary intervention (PCI) in the workup for transcatheter aortic valve replacement (TAVR), the clinical impact of coronary revascularization complexity remains largely unknown. This study sought to examine the impact of PCI complexity on clinical outcomes after TAVR in patients undergoing PCI in the preprocedural workup. This was a multicenter study including consecutive patients scheduled for TAVR with concomitant significant coronary artery disease. Complex PCI was defined as having at least 1 of the following features: 3 vessels treated, ≥ 3 stents implanted, ≥ 3 lesions treated, bifurcation with 2 stents implanted, total stent length > 60 mm, or chronic total occlusion. The rates of major adverse cardiac events (MACE), including cardiovascular mortality, myocardial infarction, and coronary revascularization were evaluated. A total of 1550 patients were included, of which 454 (29.3%) underwent complex PCI in the pre-TAVR workup. After a median follow-up period of 2 [1-3] years after TAVR, the incidence of MACE was 9.6 events per 100 patients-years. Complex PCI significantly increased the risk of cardiovascular death (HR, 1.44; 95%CI, 1.01-2.07), nonperiprocedural myocardial infarction (HR, 1.52; 95%CI, 1.04-2.21), and coronary revascularization (HR, 2.46; 95%CI, 1.44-4.20). In addition, PCI complexity was identified as an independent predictor of MACE after TAVR (HR, 1.44; 95%CI, 1.09-1.83; P = .009). In TAVR candidates with significant coronary artery disease requiring percutaneous treatment, complex revascularization was associated with a higher risk of MACE. The degree of procedural complexity should be considered a strong determinant of prognosis in the PCI-TAVR population.

Identifiants

pubmed: 38763211
pii: S1885-5857(24)00159-2
doi: 10.1016/j.rec.2024.05.002
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Marisa Avvedimento (M)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Francisco Campelo-Parada (F)

Cardiology Department, Hôpital Universitaire de Toulouse, Toulouse, France.

Luis Nombela-Franco (L)

Servicio de Cardiología, Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Quentin Fischer (Q)

Cardiology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Pierre Donaint (P)

Cardiology Department, Reims University Hospital, Reims, France.

Vicenç Serra (V)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Gabriela Veiga (G)

Servicio de Cardiología, Hospital Marqués de Valdecilla, Santander, Cantabria, Spain.

Enrique Gutiérrez (E)

Servicio de Cardiología, Hospital Gregorio Marañón, Madrid, Spain.

Anna Franzone (A)

Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

Victoria Vilalta (V)

Servicio de Cardiología, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.

Alberto Alperi (A)

Servicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Ander Regueiro (A)

Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Lluis Asmarats (L)

Servicio de Cardiología, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Henrique B Ribeiro (HB)

Cardiology Department, Heart Institute, University of São Paulo, São Paulo, Brazil.

Anthony Matt (A)

Cardiology Department, Hôpital Universitaire de Toulouse, Toulouse, France.

Antonio Muñoz-García (A)

Servicio de Cardiología, Hospital Universitario Virgen de la Victoria, Malaga, Spain.

Gabriela Tirado (G)

Servicio de Cardiología, Instituto Cardiovascular, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Marina Urena (M)

Cardiology Department, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Damien Metz (D)

Cardiology Department, Reims University Hospital, Reims, France.

Eduard Rodenas-Alesina (E)

Servicio de Cardiología, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Jose María De La Torre Hernández (JM)

Servicio de Cardiología, Hospital Marqués de Valdecilla, Santander, Cantabria, Spain.

Domenico Angellotti (D)

Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.

Eduard Fernández-Nofrerías (E)

Servicio de Cardiología, Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain.

Isaac Pascual (I)

Servicio de Cardiología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.

Pablo Vidal-Calés (P)

Servicio de Cardiología, Institut Clínic Cardiovascular, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.

Dabit Arzamendi (D)

Servicio de Cardiología, Hospital Santa Creu i Sant Pau, Barcelona, Spain.

Diego Carter Campanha-Borges (DC)

Cardiology Department, Heart Institute, University of São Paulo, São Paulo, Brazil.

Kim Hoang Trinh (KH)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Jorge Nuche (J)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Mélanie Côté (M)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.

Laurent Faroux (L)

Cardiology Department, Reims University Hospital, Reims, France.

Josep Rodés-Cabau (J)

Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada. Electronic address: josep.rodes@criucpq.ulaval.ca.

Classifications MeSH